Basic principles of therapeutic plasma exchange

被引:4
作者
Weinstein, Robert [1 ,2 ]
机构
[1] Univ Massachusetts, Dept Med, Chan Med Sch, Worcester, MA USA
[2] Univ Massachusetts, Dept Med, Chan Med Sch, 1020 Avery Meadows Way, Deland, FL 32724 USA
关键词
Plasma exchange; Therapeutic apheresis; Hypocalcemia; PLASMAPHERESIS THERAPY; APHERESIS; COMPLICATIONS;
D O I
10.1016/j.transci.2023.103675
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Therapeutic plasma exchange is a method of treatment for clinical conditions that represent diverse fields of medicine. The rationale for this mode of therapy is based on sound mathematical modeling of the synthesis and removal of large molecules, usually proteins, from the circulation. The basic assumptions underlying therapeutic plasma exchange are that a clinical illness is caused by, or related to, a pathogenic substance in the plasma, and that removing that substance from the plasma will alleviate the patient's illness. This approach has proven applicable to a wide variety of clinical conditions. Therapeutic plasma exchange is largely a safe procedure in experienced hands. The principal adverse effect, the hypocalcemic reaction, is readily ameliorated or prevented.
引用
收藏
页数:3
相关论文
共 26 条
  • [1] PLASMAPHERESIS - DEVELOPMENT AND APPLICATION IN TREATMENT OF RENAL DISORDERS
    BALOW, JE
    [J]. ARTIFICIAL ORGANS, 1986, 10 (04) : 324 - 330
  • [2] PLASMAPHERESIS THERAPY OF IMMUNOLOGICAL DISEASE - REPORT OF 9 CASES AND REVIEW OF THE LITERATURE
    CALABRESE, LH
    CLOUGH, JD
    KRAKAUER, RS
    HOELTGE, GA
    [J]. CLEVELAND CLINIC QUARTERLY, 1980, 47 (02): : 53 - 72
  • [3] CHARLTON B, 1985, J LAB CLIN MED, V105, P312
  • [4] CHOPEK M., 1980, Therapeutic Hemapheresis, P13
  • [5] COMPLICATIONS OF THERAPEUTIC PLASMA-EXCHANGE - A RECENT ASSESSMENT
    COURIEL, D
    WEINSTEIN, R
    [J]. JOURNAL OF CLINICAL APHERESIS, 1994, 9 (01) : 1 - 5
  • [6] Goss GA, 1999, J CLIN APHERESIS, V14, P114, DOI 10.1002/(SICI)1098-1101(1999)14:3<114::AID-JCA2>3.0.CO
  • [7] 2-8
  • [8] Hester J P, 1983, J Clin Apher, V1, P149, DOI 10.1002/jca.2920010306
  • [9] JONES JV, 1981, J LAB CLIN MED, V97, P589
  • [10] Kellogg R M, 1988, J Clin Apher, V4, P183, DOI 10.1002/jca.2920040409